Amsterdam UMC Location Vrije Universiteit Amsterdam

Kutatók

• SLSusan van der Lei

Futó vizsgálatok

• Toboroz

  InRAD Observational Study

  NCT07213700· Stichting International Registry for Alzheimer's Disease and other Dementias Foundation· Forrás

• Toboroz

  Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease

  NCT06416345· Amsterdam UMC, location VUmc· Forrás

• Toboroz

  The Dragon PLC Trial (DRAGON-PLC)

  NCT06914648· Maastricht University· Forrás

• Toboroz

  A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

  NCT06644781· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases

  NCT06185556· 2/3. fázis· Amsterdam UMC, location VUmc· Forrás

• Toboroz

  Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM

  NCT06630624· 1/2. fázis· M.R. Meijerink· Forrás

• Toboroz

  Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques

  NCT06623565· Amsterdam UMC, location VUmc· Forrás

• Toboroz

  Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm

  NCT05779631· Radboud University Medical Center· Forrás

• Fut, nem toboroz

  Integration of Whole-Genome Sequencing PrOfiles and ImmuNe StATus in Cancer

  NCT07796594· Amsterdam UMC, location VUmc· Forrás

• Toboroz

  CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer

  NCT07595835· 1/2. fázis· M.R. Meijerink· Forrás

• Toboroz

  Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

  NCT05834855· 3. fázis· Amsterdam UMC, location VUmc· Forrás

• Toboroz

  Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy

  NCT04833426· 3. fázis· Canisius-Wilhelmina Hospital· Forrás

• Toboroz

  Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma

  NCT05546372· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Forrás

• Toboroz

  Met Non Small Cell Cancer Registry (MOMENT)

  NCT05376891· EMD Serono Research & Development Institute, Inc.· Forrás

• Fut, nem toboroz

  A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

  NCT05160584· Janssen Pharmaceutica N.V., Belgium· Forrás

• Még nem toboroz

  Standardizing Right Hemicolectomy for Colon Cancer

  NCT04889456· Amsterdam UMC, location VUmc· Forrás

• Toboroz

  Prospective Bladder Cancer Infrastructure (ProBCI)

  NCT04503577· Prospective Bladder Cancer Infrastructure Foundation· Forrás

• Fut, nem toboroz

  A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT04557098· 2. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy

  NCT04642027· 3. fázis· University Medical Center Groningen· Forrás

• Fut, nem toboroz

  Second and Third Look Laparoscopy in pT4 Colon Cancer Patients for Early Detection of Peritoneal Metastases

  NCT03413254· 3. fázis· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Forrás

• Fut, nem toboroz

  Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT03399799· 1. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation

  NCT03173248· 3. fázis· Institut de Recherches Internationales Servier· Forrás

• Fut, nem toboroz

  Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

  NCT02811861· 3. fázis· Eisai Inc.· Forrás

• Fut, nem toboroz

  Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

  NCT01558921· 3. fázis· University Medical Center Groningen· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Vastagbélrák3 toboroz
• Alzheimer-kór2 toboroz
• Hólyagrák2 toboroz
• Máj- és epeúti rák2 toboroz
• Prosztatarák2 toboroz
• Glioblasztóma1 toboroz
• Gyermekkori daganatok1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hasnyálmirigyrák1 toboroz
• Parkinson-kór1 toboroz
• Sclerosis multiplex (SM)1 toboroz

Lezárt vizsgálatok

• Lezárult

  Use of Flow-Controlled Ventilation During CT-Guided Percutaneous Liver Tumor Ablation

  NCT07291271· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Forrás

• Lezárult

  Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision

  NCT06281769· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Forrás

• Leállították

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· 2. fázis· Pliant Therapeutics, Inc.· Forrás

• Lezárult

  Empagliflozin in Pulmonary Arterial Hypertension

  NCT05493371· 2. fázis· Amsterdam UMC, location VUmc· Forrás

• Lezárult

  Assessment of Digital Consultations on Clinical Impact and Efficiency

  NCT05413447· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Forrás

• Leállították

  A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

  NCT05282121· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

  NCT05238675· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Combining Afatinib and Concurrent Chemotherapy, Followed by Osimertinib and Concurrent Chemotherapy, in Untreated EGFR Positive NSCLC Tumors

  NCT05298176· 2. fázis· Amsterdam UMC, location VUmc· Forrás

• Lezárult

  RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood Trauma

  NCT05217758· 2. fázis· Amsterdam UMC, location VUmc· Forrás

• Leállították

  Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules

  NCT05142904· 3. fázis· Rijnstate Hospital· Forrás

• Lezárult

  A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

  NCT04771273· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

  NCT04129502· 3. fázis· Takeda· Forrás

• Lezárult

  M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)

  NCT03631706· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· 3. fázis· Shire· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

  NCT03040999· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

  NCT02576496· 1. fázis· Mundipharma Research Limited· Forrás

• Lezárult

  Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

  NCT02162563· 3. fázis· Dutch Colorectal Cancer Group· Forrás

• Lezárult

  Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

  NCT01909453· 3. fázis· Pfizer· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Alzheimer-kór241 munka · 1 vizsgálat
• Sclerosis multiplex (SM)89 munka · 1 vizsgálat
• Mielóma multiplex50 munka · 4 vizsgálat
• Depresszió36 munka · 1 vizsgálat
• Frontotemporális demencia31 munka · 0 vizsgálat
• Lewy-testes demencia28 munka · 0 vizsgálat
• Aortic aneurysm12 munka · 0 vizsgálat
• Pulmonális artériás hipertónia11 munka · 1 vizsgálat
• Barrett's oesophagus8 munka · 0 vizsgálat
• Huntington-kór7 munka · 0 vizsgálat